image
Cue Biopharma, Inc. CUE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.245
-17 %
$ 78.9 M
Market Cap
-1.28
P/E
BALANCE SHEET
61.5 M ASSETS
-32.59%
Growth Rates
1Year -32.59%
3Years -14.81%
5Years 6.29%
7Years 20.92%
10Years 0.00%
24.4 M LIABILITIES
-4.51%
Growth Rates
1Year -4.51%
3Years 5.83%
5Years 16.50%
7Years 55.66%
10Years 0.00%
37.1 M EQUITY
-43.54%
Growth Rates
1Year -43.54%
3Years -22.25%
5Years 1.77%
7Years 13.62%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Cue Biopharma, Inc.
image
Current Assets 51.5 M
Cash & Short-Term Investments 48.5 M
Receivables 1.7 M
Other Current Assets 1.24 M
Non-Current Assets 10.1 M
Long-Term Investments 151 K
PP&E 7.12 M
Other Non-Current Assets 2.81 M
Current Liabilities 17.1 M
Accounts Payable 3.5 M
Short-Term Debt 7.33 M
Other Current Liabilities 6.25 M
Non-Current Liabilities 7.36 M
Long-Term Debt 7.36 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 48.5 51.6 64.4 74.9 44.3 20.8 63.5 14.9 6.4
Short Term Investments 0 24.7 0 10.0 15.1 18.4 50.1 K 50 K 50 K
Receivables 1.7 57.3 K 3.1 1.4 0.8 0 0 0 0
Inventory 0 1 1 0 15.1 0 0.2 0 0
Other Current Assets 1.2 1.7 1.8 2.5 1.7 1.4 1.3 0.2 51.4 K
Total Current Assets 51.5 77.2 68.5 87.5 61.0 40.6 65.1 15.1 6.5
PP&E 7.1 10.7 11.9 8.9 7.2 2.8 1.7 1.0 0.7
Intangible Assets 0 0 0 0 11.7 K 0 0.2 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0.2 0.1 0.1 0.1 0.1 0.1 0 0 0
Other Long Term Assets 2.8 3.2 2.9 3.0 3.4 1.8 23.3 K 0.1 98.5 K
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 61.5 91.3 83.4 99.5 71.6 45.4 67.0 16.3 7.3
LIABILITIES
Accounts Payable 3.5 2.7 2.6 2.1 0.9 2.0 1.3 0.5 0.1
Short Term Debt 7.3 5.3 9.9 9.6 8.9 0 0 0 0
Other Current Liabilities 4.1 3.6 0.3 (2.0) (2.2) 2.2 4.0 0.5 0.2
Total Current Liabilities 17.1 11.5 12.8 16.3 11.7 6.2 5.3 1.1 0.3
Long Term Debt 7.4 14 058.4 5.1 2.4 1.3 0 0 0 0
Deferred Tax Income 0 0 0 (1.9) (4.0) 0 0 0 0
Other Liabilities 0 (14 044.3) 0 0 0 0 0 36.4 K 34.1 K
Total Liabilities 24.4 25.6 17.9 20.6 17.0 11.4 5.3 1.1 0.4
EQUITY
Common Stock 47 K 43 K 32.2 K 30.4 K 26.6 K 20.7 K 20.1 K 10.6 K 7.35 K
Retained Earnings (301.2) (250.5) (197.4) (153.3) (108.5) (71.8) (32.8) (9.6) (1.9)
Other Accumulative Comprehensive Income/Loss 0 95.9 K 0 7.13 K 10.3 K 11 K (0.7) (0.2) 44.8 K
Total Equity 37.1 65.7 65.5 78.9 54.6 34.0 61.6 15.2 6.9
Total Liabilities and Equity 61.5 91.3 83.4 99.5 71.6 45.4 67.0 16.3 7.3
SHARES OUTSTANDING
Common Shares Outstanding 45.8 35.6 31.3 28.7 22.0 20.1 20.6 20.6 20.6